Profile
Dr. David M.
Gravett is Vice President-Research & Development at Carbylan Therapeutics, Inc.
Dr. Gravett was previously employed as Vice President-Formulations & Polymer Chemistry by Angiotech Pharmaceuticals, Inc. and a Principal by Pasteur Mérieux Connaught.
He received his doctorate degree from the University of Toronto.
Former positions of David M. Gravett
| Companies | Position | End |
|---|---|---|
Carbylan Therapeutics, Inc.
Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of molecule protease inhibitors | Chief Tech/Sci/R&D Officer | 2016-04-14 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices and pharmaceuticals for oncology, wound closure and ophthalmology | Corporate Officer/Principal | - |
Pasteur Mérieux Connaught | Corporate Officer/Principal | - |
Training of David M. Gravett
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices and pharmaceuticals for oncology, wound closure and ophthalmology | Health Technology |
Carbylan Therapeutics, Inc.
Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of molecule protease inhibitors | Health Technology |
University of Natal
University of Natal Other Consumer ServicesConsumer Services College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pasteur Mérieux Connaught |
- Stock Market
- Insiders
- David M. Gravett
















